Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction

Intern Emerg Med. 2012 Sep:7 Suppl 2:S77-9. doi: 10.1007/s11739-011-0611-x. Epub 2011 May 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Anti-Idiotypic / immunology*
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / immunology
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / immunology
  • Arthritis, Rheumatoid / drug therapy*
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / immunology
  • Drug Hypersensitivity / diagnosis*
  • Drug Hypersensitivity / immunology
  • Female
  • Humans
  • Immunoglobulin E / immunology*
  • Infliximab
  • Infusions, Intravenous / adverse effects
  • Male
  • Skin Tests*

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin E
  • Infliximab